Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus

Por um escritor misterioso

Descrição

Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Full article: Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases - ScienceDirect
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases - ScienceDirect
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Privileged Scaffolds in Medicinal by Bräse, Stefan
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
BJOC - Volume 15 - 2019
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Molecules, Free Full-Text
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Degraders: The Ultimate Weapon Against Amplified Driver Kinases in Cancer
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Figure 2 from Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Exploration of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Bispecific Inhibitors Based on the Moiety of Fedratinib for Treatment of Both Hematologic Malignancies and Solid Cancers
de por adulto (o preço varia de acordo com o tamanho do grupo)